1. Optimizing API Production as a True Manufacturing Partner

    Jim Scandura, Executive Vice President, Chief Operating Officer at Avara Pharmaceutical Service discusses serving as a partner for API production.

  2. Latest Developments in Cellular and Gene Therapies
    Although numerous cellular and gene therapy products are currently in different phases of clinical trials, only 14 have been approved for use by FDA to date.
  3. An OEE Approach To Solid Dose Equipment Purchasing and Implementation

    Adam Covitt, Vice President of Federal Equipment Company discusses strategic equipment acquisition.

  4. Keys to Cultural Integration

    That’s Nice sat down with Catherine Hanley, Alcami’s Director of Marketing, to find out how to successfully integrate after a merger.

  5. Continuous Processing: Meeting the Need for New Manufacturing Strategies

    Filipe Gaspar, Vice President, R&D, Nuno Matos, Head of Continuous Manufacturing, R&D and Marco Gil, General Manager for Hovione discuss the paradigm shift in pharmaceutical production.

  6. Equipment Must Integrate
    Budgets for pharmaceutical equipment continue to increase.
  7. Sebaceous Glands in 3D

    BASF & CTIBiotech release bioprinting breakthrough.

  8. Boehringer Ingelheim and Adimab Partner on Antibodies

    BI will leverage Adimab’s platform to optimize antibodies against targets of their choice.

  9. EU Approves AstraZeneca’s Respiratory Biologic

    The European Commission (EC) approved the first-ever respiratory biologic with an 8-week maintenance dosing schedule.

  10. Marken Opens New Kit Building Facility In Shanghai

    New location combines kit building and clinical logistics to support China growth.

  11. Moving Quality to the Forefront Brings Measurable Results

    Chris Curtin, Executive Vice President and Chief Operating Officer of UPM Pharmaceuticals explains the implementation of Manufacturing Quality Assurance (MQA).

  12. Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

    Syed T. Husain, Chief Commercial Officer at Alcami explains the value of reformulation efforts.

  13. Achieving Large-Scale Cell and Gene Therapy Manufacturing

    Mark Bamforth, Cofounder and CEO, Richard Snyder, Ph.D., Chief Scientific Officer and Steve Kasok, Chief Financial Officer and Cofounder at Brammer Bio discuss the commercialization of advanced treatments.

  14. Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing

    John Moscariello, Ph.D., Vice President, Process Development at CMC Biologics discusses the QbD concept. 

  15. Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery
    Paul R. August, Vice President, and Mark J. Pincus, M.S., Senior Research Investigator, Translational Patient Cell Models at Icagen Inc., discuss the possibility of phasing out animal models.
  16. Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability

    Eunice Costa, Group Leader, Inhalation and Conrad Winters, Director Drug Product Development at Hovione explain composite particle technology.

  17. Clinical Decision-support Software to be Developed by Roche and GE Healthcare

    The two companies will look to improve individualized treatment of cancer and critical-care patients.

  18. Impact Biomedicines Acquired By Celgene

    Celgene to pay $1.1 billion upfront and up to $5.9 billion in milestone fees.

  19. Takeda Moves into Stem-Cell Therapies with Acquisition of TiGenix

    TiGenix agrees to $620-million voluntary public takeover bid from Takeda.

  20. Abzena Continues to Expand Globally

    The biopharma company is consolidating its research and administration capabilities in Cambridge, UK and San Diego, US. 

Nice Insight Research
Annual Study
A study of 163 CDMOs for use by both buyers and sellers of contract services with customer ratings
702 Respondents
313 Profiles
163 Deepdive
View Directory
Annual Study
Compare ratings for 73 CROs and clinical services providers to match buyer or seller needs
609 Respondents
124 Profiles
73 Deepdive
View Directory
Annual Study
Learn customer needs directly from 541 respondents to ensure you meet them and gain sales
541 Respondents
39 Profiles
31 Deepdive
View Directory
Annual Study
Find out the most important factors in equipment purchasing from 597 customers for the year for (bio)processing
597 Respondents
137 Profiles
90 Deepdive
View Directory
Clinical Supply
Chain Annual Study
320 customers rate key factors in supporting an emerging global clinical supply chain model
320 Respondents
22 Profiles
22 Deepdive
View Directory
Annual Study
545 buyers reveal key factors in sourcing and purchasing pharmaceutical intermediates
545 Respondents
86 Profiles
62 Deepdive
View Directory
Pharma's Almanac TV
View All Video

Road To BIO: Coming Soon To Your Screen

That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.

Facility Expansion at Abzena

John Manzello, President, US, Abzena

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

Providing a Complete Modular Solution

George Wiker, Executive Director, AES

Bringing Bioscience to Space

Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics

  • Biologics

EU Approves AstraZeneca’s Respiratory Biologic

Jan 18, 2018 3:33:16 PM

Boehringer Ingelheim and Adimab Partner on Antibodies

Jan 18, 2018 3:27:32 PM PAO-M01-18-NI-030

Sebaceous Glands in 3D

Jan 18, 2018 2:54:54 PM PAO-M01-18-NI-029
Digital Platform

Clinical Decision-support Software to be Developed by Roche and GE Healthcare

Jan 16, 2018 2:28:55 PM PAO-M01-18-NI-028

Impact Biomedicines Acquired By Celgene

Jan 16, 2018 2:15:27 PM PAO-M01-18-NI-027

Takeda Moves into Stem-Cell Therapies with Acquisition of TiGenix

Jan 16, 2018 1:08:30 PM PAO-M01-18-NI-026

Abzena Continues to Expand Globally

Jan 16, 2018 1:00:14 PM PAO-M01-18-NI-025
Analytical Testing

Analytical Testing — Contractors Take on the Challenge of Complex Molecules

Jan 12, 2018 2:00:15 PM PAO-M01-18-NI-024

Charles River Laboratories Gains Immunology Contract Research Services

Jan 12, 2018 1:05:06 PM PAO-M01-18-NI-023
Expanded Capacity

Sharp Completes Pennsylvania Facility

Jan 12, 2018 1:02:57 PM PAO-M01-18-NI-022
Product Pipeline

Moderna Announces 19 Development Candidates at JPM

Jan 12, 2018 12:58:36 PM PAO-M01-18-NI-021
Development Agreement

Arvinas Protein Degradation Technology Attracts Pfizer’s Attention

Jan 11, 2018 2:36:49 PM PAO-M01-18-NI-020

Ignyta Snapped up by Roche

Jan 11, 2018 2:33:04 PM PAO-M01-18-NI-019

Mallinckrodt Expands Rare Disease Pipeline with Sucampo Acquisition

Jan 11, 2018 1:52:50 PM PAO-M01-18-NI-017
Cell and Gene Therapy

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics


Achieving Efficient Pharmaceutical Synthesis with Process Intensification


Virtual Panel

ADCs: The Future of Biologic Drugs
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game. We spoke to some of the players to find out all about ADCs.


Innovative Technologies

Design Logic

Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
//Fix for text overflow in cards